These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6998226)

  • 21. Progress lags on vaccines to beat antimicrobial resistance.
    Makri A
    Lancet; 2019 Nov; 394(10211):1793-1794. PubMed ID: 31741447
    [No Abstract]   [Full Text] [Related]  

  • 22. [Specific prevention of dysentery. 3. Elaboration of a method of preparing live dysentery vaccine for enteral use and study of its properties].
    Belaia IuA; Gekker VD
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Oct; 46(10):125-9. PubMed ID: 4992761
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccines against enteric infections.
    Broor S; Dar L
    Trop Gastroenterol; 1992; 13(3):96-101. PubMed ID: 1488802
    [No Abstract]   [Full Text] [Related]  

  • 24. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri].
    Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity of living attenuated shigellae.
    Serény B; Tenner C; Rácz P
    Acta Microbiol Acad Sci Hung; 1971; 18(4):239-45. PubMed ID: 4950775
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vaccine preventative interventions of clinic infections - dream or reality in progressive antibiotic resistance].
    Panknin HT
    Kinderkrankenschwester; 2015 Aug; 34(8):293-300. PubMed ID: 26495535
    [No Abstract]   [Full Text] [Related]  

  • 27. [Considerations on the control of infectious diarrhea].
    Simmons SW; Goodwin MH
    Bol Oficina Sanit Panam; 1966 Apr; 60(4):293-9. PubMed ID: 4222502
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with the wide use of bacteriophages for the purpose of preventing acute intestinal diseases].
    Pogorel'skaia SA; Belova TN; Simonovich VV; Lialiaeva NA; Borodinova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):34-7. PubMed ID: 4898260
    [No Abstract]   [Full Text] [Related]  

  • 29. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.
    Chopra I; Hodgson J; Metcalf B; Poste G
    JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological evaluation of the efficiency of oral vaccination against enteropathogenic Escherichia coli.
    Kubinyi L; Kiss I; Lendvai KG
    Acta Microbiol Acad Sci Hung; 1972; 19(3):175-86. PubMed ID: 4594981
    [No Abstract]   [Full Text] [Related]  

  • 32. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination vaccine strategies to prevent enteric infections.
    Walker R; Dull P
    Vaccine; 2017 Dec; 35(49 Pt A):6790-6792. PubMed ID: 28705515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri.
    SPRINZ H; KUNDEL DW; DAMMIN GJ; HOROWITZ RE; SCHNEIDER H; FORMAL SB
    Am J Pathol; 1961 Dec; 39(6):681-95. PubMed ID: 13915950
    [No Abstract]   [Full Text] [Related]  

  • 35. Effective stimulation of the mucosal immune response by parenteral vaccination with weak antigen associated with a nucleoprotein vehicle.
    Levenson VJ; Egorova TP
    Ann N Y Acad Sci; 1994 Aug; 730():353-5. PubMed ID: 8080208
    [No Abstract]   [Full Text] [Related]  

  • 36. [Characteristics of a model of experimental Shigella pneumonia in white mice].
    Blank GF; Avetikian BG
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jan; 49(1):115-9. PubMed ID: 5010268
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic determinants of virulence in Shigella and dysenteric strains of Escherichia coli: their involvement in the pathogenesis of dysentery.
    Kopecko DJ; Baron LS; Buysse J
    Curr Top Microbiol Immunol; 1985; 118():71-95. PubMed ID: 2414072
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vaccination against the enterobacteria responsible for enteric infections].
    Sansonetti PJ
    Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACUTE DIARRHEAL DISEASE.
    GORDON JE
    Am J Med Sci; 1964 Sep; 248():345-65. PubMed ID: 14218165
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ribosomal dysentery vaccine. II. Biological trials of active protection for guinea pigs and mice].
    Levinson VI; Subbotina IuL
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):81-6. PubMed ID: 358702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.